Labidi-Galy SI, Rodrigues M, Sandoval JL, Kurtz JE, et al. Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer: phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis. Ann Oncol 2022 Nov 28:S0923-7534(22)04733-0. doi: 10.1016/j.annonc.2022.
PMID: 36564284